MAP kinase: It's been longer than fifteen minutes

Biochemical and Biophysical Research Communications

Volumn 371, Issue 1, 2008, Pages 1-4

  Sturgill, Thomas W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cell cycle; ERK1; ERK2; MAP kinase; MEK1; MEK2

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; UPREGULATION;

ANIMALS; CELL CYCLE; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 42949127699     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.002     Document Type: Short Survey

References (64)

1. Crews C.M., Alessandrini A., and Erikson R.L. Erks: their fifteen minutes has arrived. Cell Growth Differ. 3 (1992) 135-142
2. Cobb M.H., Hepler J.E., Cheng M., and Robbins D. The mitogen-activated protein kinases, ERK1 and ERK2. Semin. Cancer Biol. 5 (1994) 261-268
3. Cuevas B.D., Abell A.N., and Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26 (2007) 3159-3171
4. Meloche S., and Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26 (2007) 3227-3239
5. Torii S., Nakayama K., Yamamoto T., and Nishida E. Regulatory mechanisms and function of ERK MAP kinases. J. Biochem. 136 (2004) 557-561
6. Johnson G.L., Dohlman H.G., and Graves L.M. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr. Opin. Chem. Biol. 9 (2005) 325-331
7. Jelinek T., Catling A.D., Reuter C.W., Moodie S.A., Wolfman A., and Weber M.J. RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol. 14 (1994) 8212-8218
8. Huang W., Alessandrini A., Crews C.M., and Erikson R.L. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Proc. Natl. Acad. Sci. USA 90 (1993) 10947-10951
9. Karandikar M., Xu S., and Cobb M.H. MEKK1 binds raf-1 and the ERK2 cascade components. J. Biol. Chem. 275 (2000) 40120-40127
10. Silliman C.C., and Sturgill T.W. Phosphorylation of microtubule-associated protein 2 by MAP kinase primarily involves the projection domain. Biochem. Biophys. Res. Commun. 160 (1989) 993-998
11. Cooper J.A., and Hunter T. Major substrate for growth factor-activated protein-tyrosine kinases is a low-abundance protein. Mol. Cell. Biol. 5 (1985) 3304-3309
12. Rossomando A.J., Payne D.M., Weber M.J., and Sturgill T.W. Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc. Natl. Acad. Sci. USA 86 (1989) 6940-6943
13. Kohno M. Diverse mitogenic agents induce rapid phosphorylation of a common set of cellular proteins at tyrosine in quiescent mammalian cells. J. Biol. Chem. 260 (1985) 1771-1779
14. Rivard N., Boucher M.J., Asselin C., and L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 277 (1999) C652-C664
15. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
16. Casanovas O., Miro F., Estanyol J.M., Itarte E., Agell N., and Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275 (2000) 35091-35097
17. Bunz F., Fauth C., Speicher M.R., Dutriaux A., Sedivy J.M., Kinzler K.W., Vogelstein B., and Lengauer C. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res. 62 (2002) 1129-1133
18. Alblas J., Slager-Davidov R., Steenbergh P.H., Sussenbach J.S., and van der Burg B. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells. Oncogene 16 (1998) 131-139
19. Han J., Tsukada Y., Hara E., Kitamura N., and Tanaka T. Hepatocyte growth factor induces redistribution of p21(CIP1) p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells. J. Biol. Chem. 280 (2005) 31548-31556
20. Zhu J., Woods D., McMahon M., and Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12 (1998) 2997-3007
21. Kamakura S., Moriguchi T., and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274 (1999) 26563-26571
22. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
23. Ravi R.K., Weber E., McMahon M., Williams J.R., Baylin S., Mal A., Harter M.L., Dillehay L.E., Claudio P.P., Giordano A., Nelkin B.D., and Mabry M. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J. Clin. Invest. 101 (1998) 153-159
24. dKunnimalaiyaan M., Ndiaye M., and Chen H. Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Surgery 142 (2007) 959-964 discussion 959-64
25. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., and Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22 (2002) 3389-3403
26. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., and Lowe S.W. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22 (2002) 3497-3508
27. Palmero I., Pantoja C., and Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 395 (1998) 125-126
28. Cammarano M.S., Nekrasova T., Noel B., and Minden A. Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling. Mol. Cell. Biol. 25 (2005) 9532-9542
29. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., and Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12 (1998) 3008-3019
30. Nakagawa M., Oliva J.L., Kothapalli D., Fournier A., Assoian R.K., and Kazanietz M.G. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J. Biol. Chem. 280 (2005) 33926-33934
31. Todd D.E., Densham R.M., Molton S.A., Balmanno K., Newson C., Weston C.R., Garner A.P., Scott L., and Cook S.J. ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene 23 (2004) 3284-3295
32. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
33. Squires M.S., Nixon P.M., and Cook S.J. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366 (2002) 673-680
34. Wright J.H., Munar E., Jameson D.R., Andreassen P.R., Margolis R.L., Seger R., and Krebs E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA 96 (1999) 11335-11340
35. Ussar S., and Voss T. MEK1 and MEK2, different regulators of the G1/S transition. J. Biol. Chem. 279 (2004) 43861-43869
36. Roovers K., and Assoian R.K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22 (2000) 818-826
37. Abbott D.W., and Holt J.T. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J. Biol. Chem. 274 (1999) 2732-2742
38. Liu X., Yan S., Zhou T., Terada Y., and Erikson R.L. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23 (2004) 763-776
39. Barr F.A., Sillje H.H., and Nigg E.A. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 5 (2004) 429-440
40. Belanger L.F., Roy S., Tremblay M., Brott B., Steff A.M., Mourad W., Hugo P., Erikson R., and Charron J. Mek2 is dispensable for mouse growth and development. Mol. Cell. Biol. 23 (2003) 4778-4787
41. Giroux S., Tremblay M., Bernard D., Cardin-Girard J.F., Aubry S., Larouche L., Rousseau S., Huot J., Landry J., Jeannotte L., and Charron J. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 9 (1999) 369-372
42. Xu S., Khoo S., Dang A., Witt S., Do V., Zhen E., Schaefer E.M., and Cobb M.H. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism. Mol. Endocrinol. 11 (1997) 1618-1625
43. Wu J., Harrison J.K., Vincent L.A., Haystead C., Haystead T.A., Michel H., Hunt D.F., Lynch K.R., and Sturgill T.W. Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase. Proc. Natl. Acad. Sci. USA 90 (1993) 173-177
44. Rossomando A.J., Dent P., Sturgill T.W., and Marshak D.R. Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol. Cell. Biol. 14 (1994) 1594-1602
45. Harding A., Giles N., Burgess A., Hancock J.F., and Gabrielli B.G. Mechanism of mitosis-specific activation of MEK1. J. Biol. Chem. 278 (2003) 16747-16754
46. Sharma P., Veeranna, Sharma M., Amin N.D., Sihag R.K., Grant P., Ahn N., Kulkarni A.B., and Pant H.C. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277 (2002) 528-534
47. Brunet A., Pages G., and Pouyssegur J. Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). FEBS Lett. 346 (1994) 299-303
48. Eblen S.T., Slack J.K., Weber M.J., and Catling A.D. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol. Cell. Biol. 22 (2002) 6023-6033
49. Lefloch R., Pouyssegur J., and Lenormand P. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol. Cell. Biol. 28 (2008) 511-527
50. Pages G., Guerin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., and Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286 (1999) 1374-1377
51. Hatano N., Mori Y., Oh-hora M., Kosugi A., Fujikawa T., Nakai N., Niwa H., Miyazaki J., Hamaoka T., and Ogata M. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8 (2003) 847-856
52. Saba-El-Leil M.K., Vella F.D., Vernay B., Voisin L., Chen L., Labrecque N., Ang S.L., and Meloche S. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4 (2003) 964-968
53. Afshari C.A., Vojta P.J., Annab L.A., Futreal P.A., Willard T.B., and Barrett J.C. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209 (1993) 231-237
54. Chuang C.F., and Ng S.Y. Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346 (1994) 229-234
55. Seth A., Gonzalez F.A., Gupta S., Raden D.L., and Davis R.J. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267 (1992) 24796-24804
56. Vantaggiato C., Formentini I., Bondanza A., Bonini C., Naldini L., and Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5 (2006) 14
57. Chrestensen C.A., Shuman J.K., Eschenroeder A., Worthington M., Gram H., and Sturgill T.W. MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J. Biol. Chem. 282 (2007) 4243-4252
58. Rana B., Xie Y., Mischoulon D., Bucher N.L., and Farmer S.R. The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle. J. Biol. Chem. 270 (1995) 18123-18132
59. Hanlon M., Sturgill T.W., and Sealy L. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J. Biol. Chem. 276 (2001) 38449-38456
60. Kortenjann M., and Shaw P.E. Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts. Oncogene 11 (1995) 2105-2112
61. Li J., and Johnson S.E. ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem. Biophys. Res. Commun. (2006)
62. Cho H.N., Lee Y.J., Cho C.K., Lee S.J., and Lee Y.S. Downregulation of ERK2 is essential for the inhibition of radiation-induced cell death in HSP25 overexpressed L929 cells. Cell Death Differ. 9 (2002) 448-456
63. Waiczies S., Prozorovski T., Infante-Duarte C., Hahner A., Aktas O., Ullrich O., and Zipp F. Atorvastatin induces T cell anergy via phosphorylation of ERK1. J. Immunol. 174 (2005) 5630-5635
64. Roberts M.S., Woods A.J., Shaw P.E., and Norman J.C. ERK1 associates with alpha(v)beta 3 integrin and regulates cell spreading on vitronectin. J. Biol. Chem. 278 (2003) 1975-1985